[1]
Najafi, M.; Motevaseli, E.; Shirazi, A.; Geraily, G.; Rezaeyan, A.; Norouzi, F.; Rezapoor, S.; Abdollahi, H. Mechanisms of inflammatory responses to radiation and normal tissues toxicity: Clinical implications. Int. J. Radiat. Biol., 2018, 94(4), 335-356.
[3]
Yahyapour, R.; Amini, P.; Rezapour, S.; Cheki, M.; Rezaeyan, A.; Farhood, B.; Shabeeb, D.; Musa, A.E.; Fallah, H.; Najafi, M. Radiation-induced inflammation and autoimmune diseases. Mil. Med. Res., 2018, 5, 9.
[4]
Yahyapour, R.; Amini, P.; Rezapoor, S.; Rezaeyan, A.; Farhood, B.; Cheki, M.; Fallah, H.; Najafi, M. Targeting of inflammation for radiation protection and mitigation. Curr. Mol. Pharmacol., 2018, 11(3), 203-210.
[5]
Madan, R.; Benson, R.; Sharma, D.N.; Julka, P.K.; Rath, G.K. Radiation induced heart disease: Pathogenesis, management and review literature. J. Egypt. Natl. Canc. Inst., 2015, 27(4), 187-193.
[6]
Shimizu, Y.; Kodama, K.; Nishi, N.; Kasagi, F.; Suyama, A.; Soda, M.; Grant, E.J.; Sugiyama, H.; Sakata, R.; Moriwaki, H.; Hayashi, M.; Konda, M.; Shore, R.E. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. Bmj, 2010, 340, b5349.
[7]
Douple, E.B.; Mabuchi, K.; Cullings, H.M.; Preston, D.L.; Kodama, K.; Shimizu, Y.; Fujiwara, S.; Shore, R.E. Long-term radiation- related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki. Disaster Med. Public Health Prep., 2011, 5(S1), S122-S133.
[8]
Kawashima, R.; Kawamura, Y.I.; Kato, R.; Mizutani, N.; Toyama–Sorimachi, N.; Dohi, T. IL-13 receptor α2 promotes epithelial cell regeneration from radiation-induced small intestinal injury in mice. Gastroenterology, 2006, 131(1), 130-141.
[9]
Di Maggio, F.M.; Minafra, L.; Forte, G.I.; Cammarata, F.P.; Lio, D.; Messa, C.; Gilardi, M.C.; Bravatà, V. Portrait of inflammatory response to ionizing radiation treatment. J. Inflammation., 2015, 12(1), 14.
[10]
Raad, H.; Eskalli, Z.; Corvilain, B.; Miot, F.; De Deken, X. Thyroid hydrogen peroxide production is enhanced by the Th2 cytokines, IL-4 and IL-13, through increased expression of the dual oxidase 2and its maturation factorDUOXA2. Free Radic. Biol. Med., 2013, 56, 216-225.
[11]
Ameziane-El-Hassani, R.; Talbot, M.; Dos Santos, M.C.S.d.; Al Ghuzlan, A.; Hartl, D.; Bidart, J-M.; De Deken, X.; Miot, F.; Diallo, I.; de Vathaire, F. NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation. PNAS, 2015, 112(16), 5051-5056.
[12]
Menon, V.P.; Sudheer, A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol., 2007, 595, 105-125.
[13]
Zhou, H.; Beevers, C.S.; Huang, S. Targets of curcumin. Curr. Drug Targets, 2011, 12(3), 332-347.
[14]
Bagheri, H.; Rezapour, S.; Najafi, M.; Motevaseli, E.; Shekarchi, B.; Cheki, M.; Mozdarani, H. Protection against radiation-induced micronuclei in rat bone marrow erythrocytes by curcumin and selenium l-methionine. Iran. J. Med. Sci., 2018, 43(6), 645-652.
[15]
Darby, S.C.; Cutter, D.J.; Boerma, M.; Constine, L.S.; Fajardo, L.F.; Kodama, K.; Mabuchi, K.; Marks, L.B.; Mettler, F.A.; Pierce, L.J.; Trott, K.R.; Yeh, E.T.H.; Shore, R.E. Radiation-related heart disease: current knowledge and future prospects. Int. J. Radiat. Oncol. Biol. Phys., 2010, 76(3), 656-665.
[16]
Ding, N-H.; Jian, Li. J.; Sun, L.-Q. Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr. Drug Targets, 2013, 14(11), 1347-1356.
[17]
Bhattacharjee, A.; Shukla, M.; Yakubenko, V.P.; Mulya, A.; Kundu, S.; Cathcart, M.K. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic. Biol. Med., 2013, 54, 1-16.
[18]
Yahyapour, R.; Shabeeb, D.; Cheki, M.; Musa, A.E.; Farhood, B.; Rezaeyan, A.; Amini, P.; Fallah, H.; Najafi, M. Radiation protection and mitigation by natural antioxidants and flavonoids; Implications to radiotherapy and radiation disasters. Curr. Mol. Pharmacol., 2018, 11(4), 285-304.
[19]
Kunnumakkara, A.B.; Diagaradjane, P.; Guha, S.; Deorukhkar, A.; Shentu, S.; Aggarwal, B.B.; Krishnan, S. Curcumin sensitizes human colorectal cancer xenografts in nude mice to γ-radiation by targeting nuclear factor-κb–regulated gene products. Clin. Cancer Res., 2008, 14(7), 2128-2136.
[20]
Jagetia, G.C. In The molecular targets and therapeutic uses of curcumin in health and disease; Springer, 2007, pp. 301-320.
[21]
Tokatli, F.; Uzal, C.; Doganay, L.; Kocak, Z.; Kaya, M.; Ture, M.; Kurum, T.; Alkaya, F.; Karadag, H.; Kutlu, K. The potential cardioprotective effects of amifostine in irradiated rats. Int. J. Radiat. Oncol. Biol. Phys., 2004, 58(4), 1228-1234.
[22]
Rezaeyan, A.; Haddadi, G.H.; Hosseinzadeh, M.; Moradi, M.; Najafi, M. Radioprotective effects of hesperidin on oxidative damages and histopathological changes induced by X-irradiation in rats heart tissue. J. Med. Phys., 2016, 4(3), 182-191.
[23]
Srinivasan, M.; Prasad, N.R.; Menon, V.P. Protective effect of curcumin on γ-radiation induced DNA damage and lipid peroxidation in cultured human lymphocytes. Mutat. Res., 2006, 611(1), 96-103.
[24]
Sreejayan, N.; Rao, M.; Priyadarsini, K.; Devasagayam, T. Inhibition of radiation-induced lipid peroxidation by curcumin. Int. J. Pharm., 1997, 151(1), 127-130.
[25]
Lee, J.C.; Kinniry, P.A.; Arguiri, E.; Serota, M.; Kanterakis, S.; Chatterjee, S.; Solomides, C.C.; Javvadi, P.; Koumenis, C.; Cengel, K.A. Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat. Res., 2010, 173(5), 590-601.
[26]
Cho, Y.J.; Yi, C.O.; Jeon, B.T.; Jeong, Y.Y.; Kang, G.M.; Lee, J.E.; Roh, G.S.; Lee, J.D. Curcumin attenuates radiation-induced inflammation and fibrosis in rat lungs. Korean J. Physiol. Pharmacol., 2013, 17(4), 267-274.
[27]
Inano, H.; Onoda, M.; Inafuku, N.; Kubota, M.; Kamada, Y.; Osawa, T.; Kobayashi, H.; Wakabayashi, K. Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats. Carcinogenesis, 2000, 2(10), 1835-1841.
[28]
Patil, K.; Guledgud, M.V.; Kulkarni, P.K.; Keshari, D.; Tayal, S. Use of curcumin mouthrinse in radio-chemotherapy induced oral mucositis patients: A pilot study. JCDR, 2015, 9(8), ZC59-ZC62.
[29]
Elad, S.; Meidan, I.; Sellam, G.; Simaan, S.; Zeevi, I.; Waldman, E.; Weintraub, M.; Revel-Vilk, S. Topical curcumin for the prevention of oral mucositis in pediatric patients: Case series. Altern. Ther. Health Med., 2013, 19(3), 21-24.
[30]
Ryan, J.L.; Heckler, C.E.; Ling, M.; Katz, A.; Williams, J.P.; Pentland, A.P.; Morrow, G.R. Curcumin for radiation dermatitis: A randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat. Res., 2013, 180(1), 34-43.